Candidiasis at ICAAC.
Barr
D
D
Smart
T
T
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001682:Biological Availability; D002176:Candida albicans / Q000187:drug effects; D002180:Candidiasis, Oral / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D015725:Fluconazole / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006678:HIV / Q000187:drug effects / Q000235:genetics; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D007654:Ketoconazole / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D009154:Mutation
D000935:Antifungal Agents; D017964:Itraconazole; D015725:Fluconazole; D007654:Ketoconazole